Suppr超能文献

出院后 30 天内心力衰竭特定再入院或死亡的风险预测:来自韩国急性心力衰竭(KorAHF)注册研究的数据。

Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.

机构信息

Division of Cardiovascular Diseases, Korea National Institute of Health, Cheongju, Republic of Korea.

Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

出版信息

J Cardiol. 2019 Feb;73(2):108-113. doi: 10.1016/j.jjcc.2018.07.009. Epub 2018 Oct 22.

Abstract

BACKGROUND

Identifying patients with acute heart failure (HF) at high risk for readmission or death after hospital discharge will enable the optimization of treatment and management. The objective of this study was to develop a risk score for 30-day HF-specific readmission or death in Korea.

METHODS

We analyzed the data from the Korean Acute Heart Failure (KorAHF) registry to develop a risk score. The model was derived from a multiple logistic regression analysis using a stepwise variable selection method. We also proposed a point-based risk score to predict the risk of 30-day HF-specific readmission or death by simply summing the scores assigned to each risk variable. Model performance was assessed using an area under the receiver operating characteristic curve (AUC), the Hosmer-Lemeshow goodness-of-fit test, the net reclassification improvement (NRI), and the integrated discrimination improvement (IDI) index to evaluate discrimination, calibration, and reclassification, respectively.

RESULTS

Data from 4566 patients aged ≥40 years were included in the analysis. Among them, 446 (9.8%) had 30-day HF-specific readmission or death. The final model included 12 independent variables (age, New York Heart Association functional class, clinical history of hypertension, HF admission, chronic obstructive pulmonary disease, etiology of cardiomyopathy, systolic blood pressure, left ventricular ejection fraction, serum sodium, brain natriuretic peptide, N-terminal prohormone of brain natriuretic peptide at discharge, and prescription of β-blockers and angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists at discharge). The point risk score showed moderate discrimination (AUC of 0.710; 95% confidence interval, 0.685-0.735) and good calibration (χ=8.540, p=0.3826).

CONCLUSIONS

The risk score for the prediction of the risk of 30-day HF-specific readmission or death after hospital discharge was developed using 12 predictors. It can be utilized to guide appropriate interventions or care strategies for patients with HF.

摘要

背景

识别急性心力衰竭(HF)患者出院后再入院或死亡的高风险,将有助于优化治疗和管理。本研究旨在开发一种适用于韩国人群的 30 天 HF 特异性再入院或死亡风险评分。

方法

我们分析了韩国急性心力衰竭(KorAHF)登记处的数据来开发风险评分。该模型是通过逐步变量选择方法的多变量逻辑回归分析得出的。我们还提出了一种基于点的风险评分,通过简单地将每个风险变量的分数相加来预测 30 天 HF 特异性再入院或死亡的风险。使用接收者操作特征曲线(ROC)下面积(AUC)、Hosmer-Lemeshow 拟合优度检验、净重新分类改善(NRI)和综合判别改善(IDI)指数来评估模型性能,以分别评估判别能力、校准能力和重新分类能力。

结果

纳入了 4566 名年龄≥40 岁的患者的数据。其中,446 名(9.8%)患者在 30 天内发生 HF 特异性再入院或死亡。最终模型纳入了 12 个独立变量(年龄、纽约心脏协会功能分级、高血压临床病史、HF 入院、慢性阻塞性肺疾病、心肌病病因、收缩压、左心室射血分数、血清钠、脑利钠肽、脑利钠肽 N 末端前体在出院时、β受体阻滞剂和血管紧张素转换酶抑制剂或血管紧张素 II 受体拮抗剂的出院处方)。点风险评分显示出中等的判别能力(AUC 为 0.710;95%置信区间,0.685-0.735)和良好的校准能力(χ=8.540,p=0.3826)。

结论

使用 12 个预测因子开发了预测出院后 30 天 HF 特异性再入院或死亡风险的风险评分。它可以用于指导 HF 患者的适当干预或护理策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验